AbbVie receives positive EU committee opinion for hepatitis C drug

May 22, 2026 8:00 AM

AbbVie Inc. (NYSE: ABBV) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found